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Accepted 9 April 2013Large cell neuroendocrine carcinoma of the ovary is rare. Only
about 33 cases have been reported since 1991, most of which are
associated with ovarian surface epithelial neoplasia [1e10]. It has
been suggested that large cell neuroendocrine carcinoma arises
from neuroendocrine cells present in surface epithelial-stroma
tumors [11]. This is a report of a 70-year-old woman with a rare
case of composite large cell neuroendocrine carcinoma and a
mucinous borderline tumor in the right ovary.
A 70-year-old woman presented with progressive abdominal
distension and body weight gain of 10 kg within 1 year. She had a
past history of hypertension under regular medical control, bipolar
disorder, post-ﬁxation lumbar spine spondylolisthesis, and bilateral
knee osteoarthritis status post-total knee replacement. Body mass
index revealed 34.1 kg/m2. A pelvic mass was detected on physical
examination. Ultrasonography revealed a 16 cm  10 cm cystic
lesion with multiple septa located at the lower abdominal region.
Computed tomography revealed amultilocularmass approximately
16.4 cm 9.1 cm 15.3 cm in size. Survey of serum tumor markers
revealed elevated carcinoembryonic antigen of 3.35 ng/mL (normal
<2.5 ng/mL), but normal levels of CA125 (10.4 IU/mL; reference,
<35 IU/mL) and CA19-9 (6.83 IU/mL; reference <39 IU/mL).
Laparotomy revealed a left-sided, smooth, soft, and multi-
septated ovarian mass. Intraoperatively, all other abdominal and
pelvic organs were unremarkable. Frozen section revealed border-
linemucinous tumor. Staging surgerywas thenperformedwith total
abdominal hysterectomy, bilateral salpingo-oophorectomy, infra-
colic omentectomy, bilateral pelvic lymphadenectomy, and
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cence that was repaired by suture closure. She did not receive
adjuvant chemotherapy, but remained in relatively good health 6
months after the surgery.
The right ovary had a maximum diameter of 16 cm. The serosa
was barely intact and both the uterus and fallopian tubes were
normal. The cut surface was mainly cystic. On microscopy, there
were two distinct components. Most parts consisted of glands,
tubules, and cysts lined by mucinous epithelium consistent with
borderline tumor (Fig. 1A and B). The other small component (only
one site, < 1 cm in diameter) corresponding to a solid area con-
sisting of solid nests, sheets, and trabeculae of medium- to large-
sized cells with moderate amounts of eosinophilic or granular
cytoplasm (Fig. 1C and D). This component was positive for chro-
mogranin (Fig. 2A), synaptophysin (Fig. 2B), CD56 (Fig. 2C), and
cytokeratin (Fig. 2D).
Based on the cytologic and histologic characteristics and the
synaptophysin positivity, large-cell neuroendocrine carcinoma was
diagnosed according to the World Health Organization classiﬁca-
tion [12]. None of the sections showed tumor extension to the
serosal surface or a surface epithelial neoplasm. FIGO Stage Ia was
diagnosed.
Most cases of large-cell neuroendocrine carcinoma are associ-
ated with ovarian surface epithelial neoplasms, suggesting that it
may arise from neuroendocrine cells in epithelial-stromal tumors,
like mucinous and Brenner tumors [13e15], or germ cell tumors.
The present case contains a deﬁned mucinous tumor component
and a distinct large-cell neuroendocrine carcinoma that is positive
for chromogranin, synaptophysin, CD56, and cytokeratin.
There are four hypotheses regarding the origins of large-cell
neuroendocrine carcinoma: (1) from primitive endodermal cells
capable of differentiating into both endocrine and other cell types;
(2) from neoplastic transformation of a mature endocrine cell
component; (3) from a common stem cell capable of multidirec-
tional differentiation; or (4) from other cells in which neoplastic
transformation occurs with activation of gene sequences common
to neuroendocrine cells [2].
Because amucinousborderline tumor is considered likely toarise
from endometriosis, thus favoring a mesodermal lineage [12], theby Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Mucinous borderline tumor and large cell neuroendocrine carcinoma. The mucinous borderline tumor by (A) 40 and (B) 100magniﬁcation. The large cell neuroendocrine
carcinoma by (C) 40 and (D) 100 magniﬁcation.
Fig. 2. By immunohistochemistry, the large cell neuroendocrine carcinoma was positive for (A) chromogranin-A, (B) synaptophysin, (C) CD56, and (D) cytokeratin. All images were
200 magniﬁcation.
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teratoma, the second hypothesis may also be rejected. Although the
thirdhypothesis adequatelyexplains themixedneuroendocrine and
non-neuroendocrine tumor of endodermal origin [16], it may not beappropriate. Thus, the present case may support the fourth hy-
pothesis, because of the co-existence of amucinous epithelial tumor
containing small populations of neuroendocrine cells and a large-
cell neuroendocrine carcinoma that has large populations of such
D.-C. Ding et al. / Taiwanese Journal of Obstetrics & Gynecology 53 (2014) 270e272272cells. A previous report using the X-chromosome clonality assay
demonstrated that large cell neuroendocrine carcinomamight have
arisen from the mucinous epithelial tumor [8].
Reportson theprognosisofneuroendocrinecarcinomaassociated
with borderline mucinous tumor of the ovary are very limited. One
report on a half-solid and half-cystic mass treated with combined
chemotherapy shows good results [8]. Nevertheless, in a large series
of reviews [10], among these30 cases,16 cases diedwithin1 year and
in eight cases, there was no evidence of disease. The large cell
neuroendocrine carcinoma of ovary appears to be highly aggressive.
In the present case, the neuroendocrine carcinoma consists of only a
very small part of the tumor, whereas the other component is
borderline tumor. Hence, prognosis may be better than that of a
previous report, although close follow-up is mandatory.
We described a case of composite large-cell neuroendocrine
carcinoma and a mucinous borderline tumor of the ovary. This is
the ﬁrst report of such a kind of tumor in Taiwan. There have been
no signs of local tumor recurrence or metastases at follow-up ex-
aminations during the ﬁrst 6 months after the surgery. However,
the follow-up period is too short to conclude the survival and
recurrence. Reports on the prognosis are very limited, so close
follow-up is mandatory.
Conﬂicts of interest
All authors declare no conﬂicts of interest.
References
[1] Chen KT. Composite large-cell neuroendocrine carcinoma and surface
epithelial-stromal neoplasm of the ovary. Int J Surg Pathol 2000;8:169e74.
[2] Collins RJ, Cheung A, Ngan HY, Wong LC, Chan SY, Ma HK. Primary mixed
neuroendocrine and mucinous carcinoma of the ovary. Arch Gynecol Obstet
1991;248:139e43.[3] Eichhorn JH, Lawrence WD, Young RH, Scully RE. Ovarian neuroendocrine
carcinomas of non-small-cell type associated with surface epithelial adeno-
carcinomas. A study of ﬁve cases and review of the literature. Int J Gynecol
Pathol 1996;15:303e14.
[4] Jones K, Diaz JA, Donner LR. Neuroendocrine carcinoma arising in an ovarian
mucinous cystadenoma. Int J Gynecol Pathol 1996;15:167e70.
[5] Ohira S, Itoh K, Shiozawa T, Horiuchi A, Ono K, Takeuchi H, et al. Ovarian non-
small cell neuroendocrine carcinoma with paraneoplastic parathyroid
hormone-related hypercalcemia. Int J Gynecol Pathol 2004;23:393e7.
[6] Veras E, Deavers MT, Silva EG, Malpica A. Ovarian nonsmall cell neuroendo-
crine carcinoma: a clinicopathologic and immunohistochemical study of 11
cases. Am J Surg Pathol 2007;31:774e82.
[7] Choi YD, Lee JS, Choi C, Park CS, Nam JH. Ovarian neuroendocrine carcinoma,
non-small cell type, associated with serous carcinoma. Gynecol Oncol
2007;104:747e52.
[8] Yasuoka H, Tsujimoto M, Fujita S, Kunishige I, Nishio Y, Kodama R, et al.
Monoclonality of composite large cell neuroendocrine carcinoma and
mucinous epithelial tumor of the ovary: a case study. Int J Gynecol Pathol
2009;28:55e8.
[9] Lindboe CF. Large cell neuroendocrine carcinoma of the ovary. APMIS
2007;115:169e76.
[10] Draganova-Tacheva RA, Khurana JS, Huang Y, Hernandez E, Zhang X. Large cell
neuroendocrine carcinoma of the ovary associated with serous carcinoma
with mucin production: a case report and literature review. Int J Clin Exp
Pathol 2009;2:304e9.
[11] Sasaki E, Sasano N, Kimura N, Andoh N, Yajima A. Demonstration of neuro-
endocrine cells in ovarian mucinous tumors. Int J Gynecol Pathol 1989;8:
189e200.
[12] Tavassoli FA, Devilee P. Pathology and genetics of tumours of the breast and
female genital organs. In: World Health Organization classiﬁcation of tu-
mours. World Health Organization; 2003. p. 184.
[13] Scully RE, Aguirre P, DeLellis RA. Argyrophilia, serotonin, and peptide hor-
mones in the female genital tract and its tumors. Int J Gynecol Pathol 1984;3:
51e70.
[14] Louwerens JK, Schaberg A, Bosman FT. Neuroendocrine cells in cystic
mucinous tumours of the ovary. Histopathology 1983;7:389e98.
[15] Aguirre P, Scully RE, Dayal Y, DeLellis RA. Mucinous tumors of the ovary with
argyrophil cells. An immunohistochemical analysis. Am J Surg Pathol 1984;8:
345e56.
[16] DeLellis RA, Tischler AS, Wolfe HJ. Multidirectional differentiation in neuro-
endocrine neoplasms. J Histochem Cytochem 1984;32:899e904.
